EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Therapeutic Potential of Berberine in Obesity-Associated Neuroinflammation Through Shared Molecular Pathways: TLR4/NF-κB/MAPK, ROS/NRF2 and NLRP3

María Del Refugio Moyetón-Hernández, Cindy Bandala iD, Mariana Guadarrama-Castillo, Roberto Medina-Santillán, Eleazar Lara-Padilla

Nutrients · 2026

DOI: 10.3390/nu18183000 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Nutrients, 2026. Verfasst von María Del Refugio Moyetón-Hernández und 4 weiteren Autor:innen. Beteiligte Einrichtung: Sección de Estudios de Posgrado de Investigación, Escuela Superior de Medicina, Instituto Politécnico Nacional, Mexico City 11340, Mexico. Hauptthemen laut MEDLINE: Berberine, Obesity, Neuroinflammatory Diseases. Die Arbeit nennt 155 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Obesity is recognized as a pathological condition that induces chronic low-grade systemic inflammation capable of affecting multiple organs, including the central nervous system, thereby promoting neuroinflammation. Although adipose and neural tissues differ in their structural and functional characteristics, they share common inflammatory mechanisms involving the TLR4/NF-κB/MAPK signaling pathways, the ROS/NRF2 axis, and the NLRP3 inflammasome. This review summarizes current evidence demonstrating the ability of berberine (BBR) to modulate these shared molecular pathways across different experimental models and pathophysiological conditions, with particular emphasis on obesity-induced neuroinflammation. A narrative literature search was conducted using academic search and indexing resources, including PubMed, Scopus, Web of Science, and Google Scholar, with the literature updated through 24 August 2026. The available evidence indicates that BBR modulates these signaling pathways, reduces the production of pro-inflammatory cytokines, attenuates oxidative stress, and limits glial activation. Furthermore, several studies suggest that BBR may help preserve the functional integrity of the blood–brain barrier and reduce neuronal damage associated with neuroinflammatory processes. Available evidence suggests that BBR may modulate inflammatory and oxidative pathways involved in obesity-associated neuroinflammation; however, current findings derive mainly from preclinical studies and indirect models. Future studies are needed to determine the bioavailability, central nervous system penetration, and clinical relevance of BBR.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BerberineObesityNeuroinflammatory DiseasesHumansNF-E2-Related Factor 2AnimalsNLR Family, Pyrin Domain-Containing 3 ProteinNF-kappa BToll-Like Receptor 4Reactive Oxygen SpeciesSignal TransductionOxidative StressInflammasomesMitogen-Activated Protein Kinases

Stichwörter der Autor:innen

MAPKNF-κBNLRP3 inflammasomeNRF2TLR4berberineblood–brain barrierneuroinflammationobesityreactive oxygen species

Substanzen

BerberineNF-E2-Related Factor 2NLR Family, Pyrin Domain-Containing 3 ProteinNF-kappa BToll-Like Receptor 4Reactive Oxygen SpeciesInflammasomesMitogen-Activated Protein KinasesNFE2L2 protein, humanNLRP3 protein, human

Autor:innen und Institutionen

  • Sección de Estudios de Posgrado de Investigación, Escuela Superior de Medicina, Instituto Politécnico Nacional, Mexico City 11340, Mexico.
  • Laboratorio de Neurociencia Traslacional, Escuela Superior de Medicina, Instituto Politécnico Nacional, Mexico City 11340, Mexico.
  • Laboratorio de Enfermedades Metabólicas, Escuela Superior de Medicina, Instituto Politécnico Nacional, Mexico City 11340, Mexico.

ORCID-Profile: Cindy Bandala

Zitieren

APA

Moyetón-Hernández, M. D. R., Bandala, C., Guadarrama-Castillo, M., Medina-Santillán, R., & Lara-Padilla, E. (2026). Therapeutic Potential of Berberine in Obesity-Associated Neuroinflammation Through Shared Molecular Pathways: TLR4/NF-κB/MAPK, ROS/NRF2 and NLRP3. Nutrients. https://doi.org/10.3390/nu18183000

Vancouver

Moyetón-Hernández MDR, Bandala C, Guadarrama-Castillo M, Medina-Santillán R, Lara-Padilla E. Therapeutic Potential of Berberine in Obesity-Associated Neuroinflammation Through Shared Molecular Pathways: TLR4/NF-κB/MAPK, ROS/NRF2 and NLRP3. Nutrients. 2026. doi:10.3390/nu18183000

BibTeX
@article{MoyetnHernndez2026,
  author = {Moyetón-Hernández, María Del Refugio and Bandala, Cindy and Guadarrama-Castillo, Mariana and Medina-Santillán, Roberto and Lara-Padilla, Eleazar},
  title = {Therapeutic Potential of Berberine in Obesity-Associated Neuroinflammation Through Shared Molecular Pathways: TLR4/NF-κB/MAPK, ROS/NRF2 and NLRP3},
  journal = {Nutrients},
  year = {2026},
  doi = {10.3390/nu18183000}
}
Kostenlos starten →